Skip to main content
. 2003 Aug;71(8):4633–4641. doi: 10.1128/IAI.71.8.4633-4641.2003

TABLE 3.

Continued

Patient serum
1 2 3 4 5 6 7 8 9 15 17 18 19 20 21 22 23 24 25 26 27 30 31 32 33 34 35 36 37 38 39 42 44 45 47 48 49 50 51 52 53 54
2 1 1 1 1 1 2 1 3 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
1 2 1 2 1 2 2 2 2 1 2 3 2 2 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
1 2 1 2 2 1 1 2 1 2 2 1 1 1
1 3 1 3 3 1 1 2 2 1 2 2 3 2 1 2 1 2 3 2 1 1 1 3 1 3 1 2 1 1 1 1 2 2 1 2 1 3 1 2 1 2
1 1
2 3 1 2 1 1 1 2 1 1 1 1 3 2 1 1 1 2 2 2 1 1 1 2 1 1 1 1 2 3 2 2 1 2 2 3 3 1 1 1
1 2 2 2 1 2 1 1 2 2 2 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
2 3 1 3 2 3 2 3 2 2 2 3 3 3 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
2 3 1 3 2 2 2 3 2 2 2 3 2 2 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
1 1 1 1 3 1 2 1 1 3 1 3 1 1 3 1 1
2 3 2 2 2 2 2 2 1 1 3 2 2 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
2 3 2 1 2 1 2 2 1 1 2 2 2 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
2 3 2 3 2 2 2 3 2 1 2 3 2 3 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
2 3 1 3 2 3 2 3 2 1 2 3 2 3 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
1 1 1 1 2 1 2 2 1 1 1 1 2 1 2 1 2 2 2
1 3 2 1 1 1 2 1 1 1 2 2 2 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
1 2 1 3 3 2 1 1 3 2 3 3 3 2 2 3 1 3 3 2 1 2 2 3 1 2 1 3 2 1 1 3 3 2 2 2 2 1 3 2 2
1 1 1 1
1 1 2 2 1 1 1 1 1 2 1 1 3 2 2 1 1 2 1 3 1 2 1 2 2 1 2 2 2 2 1 1 1 2 2 1
1 1 2 2 1 1 1 1 1 3 2 2 1 1 1 2 2 2 1 2 1 3 2 1 1 1 2 1 1 1 1 1 2 1